Dermatoloxía
Servizo
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Central de Asturias (26)
2024
-
Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement — A Multicenter Cross-Sectional CLINI-AEDV Study
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 1, pp. 36-47
-
Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation
Actas Dermo-Sifiliograficas
2023
-
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 37, Núm. 12, pp. 2517-2525
2022
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2020
-
Dermatologists’ Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 10, pp. 835-846
-
Linguistic and Cultural Adaptation to Spanish of the Screening Tool Psoriatic Arthritis UnclutteRed Screening Evaluation (PURE4)
Actas Dermo-Sifiliograficas, Vol. 111, Núm. 8, pp. 655-664
2019
-
NFKBIZ and CW6 in Adalimumab Response Among Psoriasis Patients: Genetic Association and Alternative Transcript Analysis
Molecular Diagnosis and Therapy, Vol. 23, Núm. 5, pp. 627-633
-
Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364
2018
-
IL17RA gene variants and anti-TNF response among psoriasis patients
Pharmacogenomics Journal, Vol. 18, Núm. 1, pp. 76-80
2017
-
NFKBIZ in Psoriasis: Assessing the association with gene polymorphisms and report of a new transcript variant
Human Immunology, Vol. 78, Núm. 5-6, pp. 435-440
2016
-
Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis
British Journal of Dermatology, Vol. 175, Núm. 1, pp. 134-141
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2015
-
A deletion at adamts9-magi1 locus is associated with psoriatic arthritis risk
Annals of the Rheumatic Diseases, Vol. 74, Núm. 10, pp. 1875-1881
-
Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort
Journal of Dermatological Science, Vol. 80, Núm. 2, pp. 111-115
-
CDKAL1 gene variants affect the anti-TNF response among Psoriasis patients
International Immunopharmacology, Vol. 29, Núm. 2, pp. 947-949
-
Cardiovascular risk factors influence response to biological therapies in psoriasis
Journal of the American Academy of Dermatology, Vol. 73, Núm. 2, pp. 327-329
-
Influence of Fcγ receptor polymorphisms on response to anti-tumor necrosis factor treatment in psoriasis
JAMA Dermatology
-
The Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients
Pharmacogenetics and Genomics, Vol. 25, Núm. 6, pp. 313-316
-
The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients
Archives of Dermatological Research, Vol. 307, Núm. 5, pp. 405-412